Akebia Therapeutics, Inc.
AKBA
DELAYED 1 MONTH

1 insider filing · Latest: Mar 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 4, 2026Mar 5 11:55 PMJohn P. ButlerDirector, CEO and President
Purchase
69,270$1.25$86.6K3,367,064(D)

View →

Stock Options & Derivatives

No transactions found.